Enzymicals AG joins forces with Sanomol GmbH

31. August 2023

We are pleased to announce a groundbreaking collaboration: Enzymicals AG & Sanomol GmbH.

This collaboration marks a significant milestone in our journey within the chemical, biotechnology and pharmaceutical industries.

Together with renowned consultant Dr. Wagner-Solbach, Enzymicals AG entering into a transformative partnership to advance the biotechnology and pharmaceutical sectors. 🎉

Our goal is to revolutionize cell-free manufacturing and biocatalysis to drive innovation and impact.

Sanomol GmbH is a powerhouse for chemical and biotechnological solutions!

Sanomol specializes in connecting customers and suppliers to create value and innovation through chemdemand, scaledemand and trackdemand. Sanomol´s expertise fits seamlessly into Enzymical´s shared vision of progress.

🤝🏼 About the collaboration:

This collaboration ushers in a new era of growth and innovation. Merging the breakthrough enzyme products and technologies of Enzymicals AG, a long-time CRO for Big-Pharma, with the strategic capabilities of Sanomol GmbH promises to penetrate untapped markets, accelerate scalability and optimize sales strategies.

Together, we’re shaping the future of biotechnology and pharmaceuticals, redefining what’s possible.